Literature DB >> 3920178

The bacteriolytic action of MT-141, a new cephamycin antibiotic, on gram-negative bacteria.

T Tsuruoka, Y Yamada, H Goi, K Miyauchi, A Miyata, S Inouye, F Ishino, A Hirata, M Matsuhashi.   

Abstract

MT-141, a new cephamycin (7 alpha-methoxy-cephalosporin) antibiotic with a D-cysteine moiety in its 7 beta-side chain, has binding affinities to penicillin-binding proteins of Escherichia coli and an inhibitory action on their transpeptidase activity similar to those of other structurally related cephamycins. Yet this antibiotic was found to exert an exceedingly strong and rapid lytic action on sensitive Gram-negative bacteria such as E. coli, Klebsiella pneumoniae, Serratia marcescens and Salmonella enteritidis. Not only rapidly growing cells, but also slowly growing dense cells of the above bacteria could be lysed by this antibiotic at low concentrations. In the presence of 20% sucrose, low concentrations of MT-141 induced smooth-surfaced single and twin bulges of the putative growth zone of the cells and irregularly orientated rough-surfaced bulges. Probably the 7 beta-side chain structure of this antibiotic is involved in its rapid and strong bacteriolytic action.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3920178     DOI: 10.1093/jac/15.2.159

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  3 in total

1.  Effect of inoculum size on bacteriolytic activity of cefminox and four other beta-lactam antibiotics against Escherichia coli.

Authors:  F Soriano; R Edwards; D Greenwood
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

2.  Novel morphological changes in gram-negative bacteria caused by combination of bulgecin and cefmenoxime.

Authors:  M Nakao; K Yukishige; M Kondo; A Imada
Journal:  Antimicrob Agents Chemother       Date:  1986-09       Impact factor: 5.191

3.  Molecular cloning of the gene of a penicillin-binding protein supposed to cause high resistance to beta-lactam antibiotics in Staphylococcus aureus.

Authors:  M Matsuhashi; M D Song; F Ishino; M Wachi; M Doi; M Inoue; K Ubukata; N Yamashita; M Konno
Journal:  J Bacteriol       Date:  1986-09       Impact factor: 3.490

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.